Milestone Pharmaceuticals Inc (MIST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -55,229 | -23,185 | -8,086 | N/A |
| Depreciation Amortization | 38 | 10 | 8 | N/A |
| Other Working Capital | 2,848 | 1,496 | -164 | N/A |
| Other Operating Activity | 1,191 | 633 | 190 | 0 |
| Operating Cash Flow | $-51,152 | $-21,046 | $-8,052 | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 29 | 16,003 | -15,987 | N/A |
| PPE Investments | -413 | -5 | -36 | N/A |
| Investing Cash Flow | $-384 | $15,998 | $-16,023 | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 85,407 | 461 | 20 | N/A |
| Other Financing Activity | 0 | 79,654 | 30,702 | 0 |
| Financing Cash Flow | $85,407 | $80,115 | $30,722 | $N/A |
| Beginning Cash Position | 85,947 | 10,880 | 4,233 | N/A |
| End Cash Position | 119,818 | 85,947 | 10,880 | N/A |
| Net Cash Flow | $33,871 | $75,067 | $6,647 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -51,152 | -21,046 | -8,052 | N/A |
| Capital Expenditure | -413 | -5 | -36 | N/A |
| Free Cash Flow | -51,565 | -21,051 | -8,088 | 0 |